Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Journal of Laboratory Medicine
>
2014
>
>
9
Volume:
Issue:
9
1. Comparison and analysis of the reference intervals of 9 analytes with current industry standards in routine chemistry
Page:709—711
2. Study on the risk values of glycated hemoglobin in diabetes mellitus and pre-diabetes
Page:701—704
3. Meta analysis of the level of plasma D-dimer in patients with ovarian cancer
Page:696—700
4. The expression of microRNAs in serum of patients with colorectal cancer and its clinical significance
Page:691—695
5. Characteristics and significance of atypical flow cytometric immunophenotype in plasma cell myeloma
Page:687—690
6. The preliminary study of the differential diagnosis of ascites using Golgi glycoprotein 73 and alpha fetal protein
Page:683—686
7. Establishment of detection method for serum circulating Bmi-1 mRNA and its application in diagnosis of colorectal cancer
Page:678—682
8. Correctly understand and use analytical sensitivity and limit of detection
Page:669—672
9. Advances of long noncoding RNA in primary liver cancer
Page:665—668
10. Progress of GP73 as a new tumor marker for clinical application
Page:661—664
11. The prospect of cytochrome P450 in tumor laboratory diagnosis and personalized medicine
Page:657—660
12. Clinical application of microRNA in gastric cancer
Page:653—656
13. Clinical scheme design of in vitro tumor diagnostic reagents
Page:645—648
14. The application and future development of tumor markers
Page:641—644
15. Influence of some herbal medicines and foods on the INR of patients under warfarin therapy
Page:715—718
16. NaF· EDTA-K2 negatively bias blood lipids and lipoproteins measurement in pregnant women
Page:705—708
17. The applications of chromatin immunoprecipitation in the study on the downstream target genes of androgen receptor in prostate cancer cells
Page:673—677
18. A new molecular marker for myeloproliferative neoplasms:CALR mutations
Page:649—652
19. Progress on markers for curative effect monitoring in chronic hepatitis B
Page:646—648
20. Recent advances in research of cofactor C1q related diseases
Page:642—645
21. Investigation and analysis of current application status of testing items of clinical laboratories in China
Page:637—641
22. Study of appropriateness of laboratory reports for clinical hematology in China
Page:632—636
23. Clinical and molecular characteristics of bloodstream infection caused by K. pneumonia
Page:627—631
24. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae in hospitalized children
Page:622—626
25. Expression of miR-145 in breast cancer and its role in invasion and migration of breast cancer cells
Page:613—616
26. Trueness evaluation of 13 routine measurements for serum uric acid
Page:609—612
27. The relationship between mast cells-associated antibodies and molecules and autoimmune liver disease
Page:617—621
28. Development of a LC-MS/MS method for the simultaneous determination of metanephrine and norepinephrine in human plasma
Page:605—608
29. Current problems and solution for urinary albumin measurements
Page:586—588
30. Current situation and prospect of the complement system abnormality in the kidney disease
Page:580—582
31. Highlight on clinical application and standardization of urinary albumin
Page:577—579
32. Diagnostic value of serum anti-phospholipase A2 receptor antibodies (PLA2R) in idiopathic membranous nephropathy
Page:595—599
33. Microfluidic chip digital PCR technology and its clinical application
Page:592—594
34. Risk management in clinical laboratory
Page:589—591
35. Negative interference by calcium dobesilate in uricase-peroxidase coupled assays of serum uric acid
Page:600—604